Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (MBM; CheckMate 204) Meeting Abstract
| Authors: | Tawbi, H.; Forsyth, P.; Hodi, F. S.; Lao, C.; Moschos, S.; Hamid, O.; Atkins, M. B.; Lewis, K.; Thomas, R. P.; Glaspy, J. A.; Jang, S.; Algazi, A.; Khushalani, N. I.; Postow, M. A.; Pavlick, A. C.; Ernstoff, M.; Reardon, D. A.; Balogh, A.; Rizzo, J.; Margolin, K. |
| Abstract Title: | Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (MBM; CheckMate 204) |
| Meeting Title: | 2019 Cancer Conference of the National Cancer Research Institute (NCRI) |
| Journal Title: | British Journal of Cancer |
| Volume: | 121 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 3-5 |
| Meeting Location: | Glasgow, Scotland |
| ISSN: | 0007-0920 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2019-10-01 |
| Start Page: | 20 |
| Language: | English |
| ACCESSION: | WOS:000505173600055 |
| PROVIDER: | wos |
| PMCID: | PMC6891220 |
| PUBMED: | 31591445 |
| DOI: | 10.1038/s41416-019-0555-x |
| Notes: | Meeting Abstract: 55 -- Source: Wos |
